GHRP-2

Approved (multiple countries)

Growth Hormone Releasing Peptide-2

Category
Growth Hormone
Aliases
Pralmorelin, KP-102
Administration
Subcutaneous injection

Timing

A general projection of what people report noticing over time, based on the known mechanism and reported use patterns. It is not a guarantee and individual experience varies considerably.

  1. 1

    1–2 Weeks

    Increased appetite is often the most immediately noticeable effect, alongside subtly improved sleep.

  2. 2

    3–4 Weeks

    Recovery after exercise may start to feel modestly improved.

  3. 3

    5–7 Weeks

    Early shifts in body composition may begin to be noticed by consistent users.

  4. 4

    8–10 Weeks

    Continued use is commonly associated with steadier energy and recovery.

  5. 5

    11–15 Weeks

    Changes in muscle tone or fat distribution may become more apparent.

  6. 6

    16–20 Weeks

    This period is often described as when composition changes feel most noticeable.

  7. 7

    21–24 Weeks

    Users typically assess whether to continue, adjust, or cycle off by this stage.

⚠️ Research context only. This is not medical advice and results are not guaranteed.